Search

everythinglearnresearchcommunity

for

Search:↓

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

A woman was diagnosed with porphyria cutanea tarda and improved with phlebotomy and lifestyle changes.

Anti-Müllerian hormone is a specific marker for ovarian issues in women with conditions like PCOS.

Metformin effectively improves metabolic symptoms in women with PCOS, while alfacalcidiol does not have a significant impact.

Metformin improved insulin resistance and BMI in overweight Taiwanese women with PCOS, and a 2-hour insulin test may be a good screening tool.

Women with PCOS and polycystic ovaries have higher male hormone levels and more insulin resistance, especially if they are overweight.

Higher androstenedione levels in women with PCOS are linked to more severe symptoms.

Obesity changes androgen levels in women with PCOS, leading to higher testosterone relative to androstenedione.

Young women with PCOS and no other heart risk factors have normal heart function.

Blocking glucocorticoid receptors improves glucose metabolism in a PCOS mouse model.

Finasteride, CPA, and flutamide are all equally effective in reducing excessive hair growth in women.

Some parents have a mild form of congenital adrenal hyperplasia without symptoms, and they usually don't need treatment.

Obesity affects skin health, causing conditions like acanthosis nigricans and may require different treatment approaches.

Alfacalcidiol and metformin together lowered testosterone in women with PCOS, but did not significantly improve acne, hair growth, or pregnancy rates.

Young Czech women with PCOS have a higher risk of heart problems and should be regularly checked for cholesterol and glucose issues.

Testosterone replacement therapy improved blood sugar and fat levels without raising prostate cancer risk in Japanese men with low testosterone.

Higher levels of unbound testosterone are linked to increased insulin resistance, especially in women with polycystic ovary syndrome.

Metformin works better for adolescent girls with PCOS who have certain genetic variations.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

A new gene, JMJD1C, may affect testosterone levels in men.

Minoxidil works faster and is more cost-effective for treating hair loss, but platelet-rich plasma microneedling can be an alternative for those who can't use minoxidil.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

A teenage girl had both a rare ovarian tumor and a severe form of polycystic ovarian syndrome.

Higher cell number PRP improves hair density and diameter more than lower cell number PRP.

Blood AMH levels are higher in women with PCOS than in those with other similar conditions.

Women with only irregular periods or excess hair have a better hormone profile than those with full PCOS, but both groups are similar, indicating a need for better PCOS diagnosis methods.

Spironolactone is a low-cost, effective, and generally safe treatment for various skin conditions related to hormones.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

DHT may increase the risk of heart disease and death in elderly men.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.